Airsculpt Technologies, Inc. (AIRS)
About Airsculpt Technologies, Inc.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $151.8M
- Net income
- -$11.7M
- Total assets
- $187.3M
- Market cap
- $360.5M
- Operating margin
- -7.6%
- Net margin
- -7.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $151.8M
- Operating expenses
- $163.4M
- Operating income
- -$11.6M
- Income tax
- -$6.0M
- Net income
- -$11.7M
- EPS (basic)
- $-0.19
- EPS (diluted)
- $-0.19
Balance sheet
- Total assets
- $187.3M
- Current assets
- $15.5M
- Total liabilities
- $99.6M
- Current liabilities
- $27.9M
- Shareholders’ equity
- $87.7M
Cash flow
- Operating cash flow
- $3.1M
- Investing cash flow
- -$2.4M
- Financing cash flow
- -$478.0K
- Net cash flow
- $214.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $360.5M
- EPS (diluted)
- $-0.19
- Shares outstanding
- 81.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 29, 2021
Airsculpt Technologies, Inc. (AIRS) Stock Price
- Reported a net loss of $11.7M in FY2025.
- Revenue grew 14% from FY2021 to FY2025.
- Trading 62% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Airsculpt Technologies, Inc..
Write a review
News about Airsculpt Technologies, Inc.
News & sentiment via Polygon.io
Airsculpt Technologies, Inc.: frequently asked questions
Is Airsculpt Technologies, Inc. an American company?
Airsculpt Technologies, Inc. is a US-based company headquartered in Miami Beach, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Airsculpt Technologies, Inc. headquartered?
Airsculpt Technologies, Inc. is headquartered in Miami Beach, Florida, United States.
Is Airsculpt Technologies, Inc. publicly traded?
Yes — Airsculpt Technologies, Inc. is a publicly traded company. Its stock trades under the ticker symbol AIRS on the NASDAQ.
What does Airsculpt Technologies, Inc. do?
Airsculpt Technologies, Inc. is an American Medical Devices company in the Health & Beauty sector.
